Frank Akpoviri
Biographic Data
| ID | 5158645 |
|---|---|
| NAME | Frank Akpoviri |
| GIVEN NAMES | Frank |
| FAMILY NAME | Akpoviri |
| SIGNATURE | AKPOVIRI F |
| AFFILIATIONS | National University of Malaysia |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Prioritising human rights principles in synthetic biology innovation and patenting
Human rights discourses traditionally centre around interference with the freedom of expression, association and movement, or other abuses by states and their agents. Nonetheless, new biotechnologies, specifically synthetic biology, and patent rights that contend with human rights principles, equally deserve attention. Synthetic biology is a new phase of modern biotechnology pioneering essential treatments, and other breakthrough solutions to hum…
Digital Sequence Information and the Access and Benefit-Sharing Obligation of the Convention on Biological Diversity
With the advent of synthetic biology, scientists are increasingly relying on digital sequence information, instead of physical genetic resources. This article examines the potential impact of this shift on the access and benefit-sharing (ABS) regime of the Convention on Biological Diversity (CBD) and the Nagoya Protocol. These treaties require benefit-sharing with the owners of genetic resources. However, whether "genetic resources" include digit…
Synthetic Biology and Biosafety Governance in the European Union and the United States
This article examines how synthetic biology, which is the construction of novel biological parts, devices, and systems, as well as the modification of regular organisms, impacts biosafety regimes in the European Union (EU) and the United States (US). The article examines the nature and benefits of synthetic biology. It then reviews associated biosafety challenges, before analysing the suitability of governance frameworks in the EU and the US in d…
Mandatory labelling of genetically modified (GM) foods
Digital Sequence Information and the Access and Benefit-Sharing Obligation of the Convention on Biological Diversity
With the advent of synthetic biology, scientists are increasingly relying on digital sequence information, instead of physical genetic resources. This article examines the potential impact of this shift on the access and benefit-sharing (ABS) regime of the Convention on Biological Diversity (CBD) and the Nagoya Protocol. These treaties require benefit-sharing with the owners of genetic resources. However, whether "genetic resources" include digit…
Mandatory labelling of genetically modified (GM) foods
Synthetic Biology and Biosafety Governance in the European Union and the United States
This article examines how synthetic biology, which is the construction of novel biological parts, devices, and systems, as well as the modification of regular organisms, impacts biosafety regimes in the European Union (EU) and the United States (US). The article examines the nature and benefits of synthetic biology. It then reviews associated biosafety challenges, before analysing the suitability of governance frameworks in the EU and the US in d…
Digital Sequence Information and the Access and Benefit-Sharing Obligation of the Convention on Biological Diversity
With the advent of synthetic biology, scientists are increasingly relying on digital sequence information, instead of physical genetic resources. This article examines the potential impact of this shift on the access and benefit-sharing (ABS) regime of the Convention on Biological Diversity (CBD) and the Nagoya Protocol. These treaties require benefit-sharing with the owners of genetic resources. However, whether "genetic resources" include digit…
Prioritising human rights principles in synthetic biology innovation and patenting
Human rights discourses traditionally centre around interference with the freedom of expression, association and movement, or other abuses by states and their agents. Nonetheless, new biotechnologies, specifically synthetic biology, and patent rights that contend with human rights principles, equally deserve attention. Synthetic biology is a new phase of modern biotechnology pioneering essential treatments, and other breakthrough solutions to hum…
Biology (3 works) · Biotechnology (3 works) · Business (3 works) · Genetically Modified Organisms Research (3 works) · CRISPR and Genetic Engineering (2 works) · Genetics (2 works) · Intellectual Property and Patents (2 works) · Law, AI, and Intellectual Property (2 works) · Synthetic biology (2 works) · Biochemistry (1 work)